What Bioness does

Bioness Medical, Inc. is a privately held medical device company headquartered in Valencia, California, founded in 2004, that develops and commercializes technologies for the rehabilitation of people living with the effects of stroke, brain injury, and other neurological conditions. Its portfolio is built around Functional Electrical Stimulation (FES) and Neuromuscular Electrical Stimulation (NMES) technologies and includes the L300 Go System (foot drop and thigh weakness), the L360 Thigh System (leg strengthening), the H200 Wireless Hand Rehabilitation System (hand function), the Vector Gait and Safety System (ceiling-mounted dynamic body weight support), the BITS software-based therapy platform with the newer BITS Functional Reality immersive layer, the AURA bilateral upper-extremity exoskeleton (in development), the Haloplex dynamic body weight support system (in development), and the Portable Neuromodulation Stimulator (PoNS) System acquired in April 2026. The company also acquired Harmonic Bionics in June 2025, consistent with its push into robotics and exoskeleton capabilities.

The business sells capital equipment, consumables, and software primarily to hospitals, rehabilitation hospitals, outpatient clinics, and skilled nursing facilities through a direct enterprise sales motion, with a complementary home-use program that allows patients to access certain devices such as the L300 Go outside clinical settings. Revenue mechanics include hardware sales across the device portfolio, recurring software licensing through BITS/BITS FR, training and education services via Bioness Academy, and consumable/supply fulfillment. Pricing is quote-based and not publicly disclosed. Supporting infrastructure includes the Bioness Academy virtual training platform and a 'Facility Finder' indicating an established clinical installed base.

Recent strategic activity indicates active portfolio expansion through acquisitions (Harmonic Bionics in June 2025, PoNS System in April 2026), product launches (BITS Functional Reality in October 2025, AURA and Haloplex in development), and the appointment of Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer in June 2026, positioning Bioness as a multi-modality neurorehabilitation platform spanning FES, body weight support, immersive software, exoskeleton, and non-invasive neuromodulation.

Name

Bioness

Legal name

Bioness Medical, Inc.

Website

https://bioness.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

251–500 employees

Short description

Bioness Medical is a privately held medical device company developing functional electrical stimulation, body weight support, software-based therapy, exoskeleton, and neuromodulation technologies for neurorehabilitation of stroke, brain injury, and other neurological conditions, sold to hospitals, rehabilitation clinics, and home users.

Ownership category

akta.pro rank

Product category

Neurorehabilitation Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Neurorehabilitation devices
• Functional electrical stimulation
• Medical rehabilitation equipment
• Stroke rehabilitation technology
• Robotic therapy systems

Headquarters

HQ city

Valencia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Hardware Sales: Sale of rehabilitation medical devices including the L300 Go, L360, H200 Wireless, Vector, AURA, and Haloplex systems. Devices are sold to healthcare facilities and for home use, likely as capital equipment purchases with potential consumable/accessory revenue.
2. Software Platform Licensing: BITS and BITS Functional Reality software platforms are licensed to rehabilitation facilities as therapy solutions, providing recurring software licensing revenue.
3. Training and Education Services: Bioness Academy provides virtual training and education to clinicians, potentially generating professional services and training revenue.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Bioness Medical, Inc. designs, develops, and sells medical rehabilitation devices and software platforms for neurorehabilitation. Its portfolio includes Functional Electrical Stimulation (FES) and Neuromuscular Electrical Stimulation (NMES) systems for foot drop, thigh weakness, and hand impairment (L300 Go, L360, H200 Wireless), robotic dynamic body weight support systems (Vector), a bilateral upper-extremity exoskeleton (AURA), an interactive touchscreen therapy platform with immersive BITS Functional Reality, and the non-invasive PoNS neuromodulation system. Products are sold primarily to hospitals, rehabilitation centers, outpatient clinics, and skilled nursing facilities, with a complementary home use program for individual patients.

Product overview

Bioness Medical, Inc. develops a portfolio of medical technologies focused on neurorehabilitation and recovery for people living with the effects of stroke, brain injury, and other conditions. The company's product portfolio operates as a platform-plus-modules architecture consisting of: (1) Functional Electrical Stimulation (FES) devices including the L300 Go System for foot drop correction, L360 Thigh System for leg strengthening, and H200 Wireless Hand Rehabilitation System for hand function; (2) Robotics and body weight support systems including the Vector Gait and Safety System and Haloplex (in development); (3) Software-based therapy platforms including the BITS platform with immersive BITS Functional Reality capability; (4) Exoskeleton technology with the AURA bilateral upper-extremity exoskeleton; and (5) Acquired non-invasive neuromodulation technology with the PoNS (Portable Neuromodulation Stimulator) System. The portfolio serves both patients and clinicians providing care for them, supported by the Bioness Academy training platform.

Differentiator

Problem solved

Functional benefit

Brands

• Bioness Academy: A comprehensive virtual training platform designed to support clinicians in advancing their expertise in neuro rehabilitation. Offers self-paced web-based courses, a resource library with product-specific guides and best practice materials, and on-demand webinars led by expert faculty.

Products and services

• L300 Go System Functional electrical stimulation (FES) system that stimulates the nerves and muscles that lift the foot to help correct foot drop and thigh weakness, enabling more natural walking across various terrains for patients with neurological conditions. Designed for healthcare facilities and home use.
• L360 Thigh System Combines neuromuscular electrical stimulation (NMES) and functional electrical stimulation (FES) to strengthen leg muscles, improve knee stability, and prevent or slow muscle loss due to disuse in patients with neurological conditions.
• H200 Wireless Hand Rehabilitation System Wireless functional electrical stimulation (FES) system that improves hand function so patients can return to activities of daily living, used by clinicians and patients with hand impairment due to neurological conditions.
• Vector Gait and Safety System Ceiling-mounted robotic system that uses dynamic body weight support to minimize injury risk for rehabilitation patients and therapists while maximizing clinical efficiencies and outcomes during gait and therapy activities.
• Bioness Integrated Therapy System (BITS) All-in-one software-based therapy system that uses an interactive touchscreen display to challenge, assess, and track a patient's deficiencies in vision, cognition, and balance, helping rehabilitation facilities improve clinical utility, patient engagement, and clinician efficiency.
• BITS Functional Reality (BITS FR) Immersive rehabilitation system that transports patients into everyday environments within the clinic to support their recovery through engaging therapy sessions built on the BITS software platform.
• PoNS (Portable Neuromodulation Stimulator) System Non-invasive, mobility-enhancing neuromodulation system acquired by Bioness Medical in April 2026, expanding the company's neurorehabilitation portfolio and patient access to non-invasive neuromodulation therapy.
• Bioness Academy Virtual training and education platform supporting clinicians in advancing their expertise in neurorehabilitation, offering self-paced web-based courses, a resource library with product-specific guides and best practice materials, and on-demand webinars led by expert faculty.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Ekso Bionics: Ekso Bionics develops robotic exoskeletons and wearable devices for medical and industrial use, including the EksoNR for stroke and acquired brain injury rehabilitation. Direct overlap with Bioness's Vector, AURA, and Haloplex lines in neurorehabilitation robotics.
• Hocoma (DIH Medical): Hocoma, part of DIH Medical, is a global leader in robotic and sensor-based rehabilitation devices for gait, balance, and arm therapy (Lokomat, Armeo). Closely comparable to Bioness's Vector and AURA in robotics-based neurorehabilitation.
• BTL Industries: BTL manufactures non-invasive medical devices including electrotherapy, focused shockwave, and robotic rehabilitation equipment (BTL-Emsculpt, BTL robotics). Comparable to Bioness across electrotherapeutic and rehabilitation device categories.
• Restorative Therapies: Restorative Therapies manufactures functional electrical stimulation (FES) cycling and therapy systems (RT300, Xcite) for individuals with neurological impairments such as spinal cord injury, stroke, and MS. Directly overlaps with Bioness's L300 Go and L360 FES platforms.
• Saebo: Saebo designs and distributes upper-extremity rehabilitation devices (SaeboGlove, SaeboReach, SaeboStim) for stroke and neurological patients. Directly comparable to Bioness's H200 Wireless for hand and arm rehabilitation.
• Tyromotion: Tyromotion develops robotic and sensor-based rehabilitation devices for upper and lower extremities (Armeo, PABLO, Diego). Comparable to Bioness's Vector and AURA in robotic and technology-assisted neurorehabilitation.
• AlterG: AlterG manufactures anti-gravity treadmill systems used in physical therapy and rehabilitation to enable earlier, safer gait training. Comparable to Bioness's Vector Gait and Safety System for body-weight-supported rehabilitation.
• ReWalk Robotics: ReWalk Robotics develops wearable exoskeleton systems for individuals with spinal cord injury and stroke (ReWalk Personal 6.0, ReStore). Comparable to Bioness's AURA exoskeleton and broader exoskeleton-driven rehabilitation strategy.

Broad incumbents

• Parker Hannifin (Indego): Parker Hannifin's Indego division produces wearable exoskeletons for clinical and personal use in spinal cord injury and stroke rehabilitation. A larger diversified industrial incumbent with a focused exoskeleton product line comparable to Bioness's AURA.
• Ottobock: Ottobock is a global leader in prosthetics, orthotics, and rehabilitation technology, including FES devices (L300 predecessor line was acquired by Ottobock from Bioness historically, though Bioness retained its own). Broad incumbent with overlapping prosthetics, orthotics, and rehab-tech product lines relative to Bioness's portfolio.

Market position

Competitive moat4 records

Key highlights7 records

Customer concentration

• Xx.com/bionessliveon
• Facebookfacebook.com/bionessliveon
• LinkedInlinkedin.com/company/bioness-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioness